BioScale Grabs $25M Round

Xconomy Boston — 

BioScale, a Cambridge, MA-based maker of life sciences research and diagnostics tools that analyze proteins, reports today it has nailed down a $25 million round of financing. China’s Morningside Venture led the new round, which included investments from the company’s previous backers New Science Ventures and WFD Ventures, both of which are located in New York City, as well as London-based F2 Ventures and individuals. BioScale, founded in 2002, reports that the new financing is intended to fund an expansion of sales and manufacturing of its protein analysis tools.